Evoke Pharma (NASDAQ:EVOK) Stock Price Crosses Below 200 Day Moving Average of $0.87

Evoke Pharma, Inc. (NASDAQ:EVOK) shares passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.87 and traded as low as $0.41. Evoke Pharma shares last traded at $0.49, with a volume of 10,780 shares.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Evoke Pharma in a report on Saturday. They issued a “sell” rating on the stock.

Evoke Pharma Stock Up 6.1 %

The firm has a market capitalization of $4.12 million, a PE ratio of -0.21 and a beta of 0.38. The company has a 50-day moving average of $0.57 and a 200 day moving average of $0.87.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings results on Thursday, March 14th. The specialty pharmaceutical company reported ($0.59) earnings per share (EPS) for the quarter. Evoke Pharma had a negative net margin of 150.43% and a negative return on equity of 517.99%. The business had revenue of $1.68 million for the quarter.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.